Alamar Biosciences Inc.
ALMR | NASDAQ
$28.89
-$1.71 (-5.59%)
Nov 2, 2026, 3:46 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Revenue | 29.43M | 26.04M |
Cost of Revenue | 11.71M | 11.58M |
Gross Profit | 17.72M | 14.46M |
Operating Income | -13.53M | -12.35M |
Interest Income | 1.88M | 539K |
Pretax Income | -13.29M | -20.86M |
Net Income | -13.2M | -21.33M |
Selling & General & Admin | 17.43M | 13.79M |
Research & Development | 13.82M | 13.02M |
Other Expenses | n/a | n/a |
Operating Expenses | 31.25M | 26.8M |
Interest Expense | 224K | 223K |
Selling & Marketing Expenses | n/a | n/a |
Cost & Expenses | 42.96M | 38.38M |
Income Tax Expense | -93K | 464K |
Shares Outstanding (Basic) | 58.67M | 69.31M |
Shares Outstanding (Diluted) | 58.67M | 69.31M |
EPS (Basic) | -0.22 | -0.31 |
EPS (Diluted) | -0.22 | -0.31 |
EBITDA | -13.07M | -19.47M |
EBIT | -13.07M | -20.64M |
Depreciation & Amortization | n/a | 1.17M |
Add to Watchlist
Select watchlists to add or remove ALMR